1Akio Naeal, Yasuhito Kawamura and Takuya kodama. Thirteenweek intravenous repeated dose toxicity study of T-3762, A novel parenteral quinolone antimierobial anent, and four-week recobvery test in eynomologus monkeys. The Japanese journal of antibiotics, 1998,11:681.
2Yasuhit Kawamura, Nobuko kito, et al. Three months intravenous repeated dose toxicity study of T-3762 in rats. The Japanese journal of antibiotics, 1998,12: 623.
4Yoshikazu Fukuoka, et al. In vivo antibacterial activitiesof Pazufloxacin, a new quinolonedefivative J . Antimicrobial agents and chemotherapy, 1993 , 5: 384-392.
5H. Kobayashi. Interim Resultsfroma Multcentre ClinicaTrial of T- 3761 in Japan J. Drugs,1995,49(Suypl 2):470-471.
二级参考文献1
1Nakashima M Uemura K Kosuge K et al.Phase Ⅰ clinical study of pazufloxacin mesilate [J].Japan J Chemother,1999,47(1):141-141.